Affiliation:
1. Curitiba’s City Council
2. Faculdades Pequeno Príncipe
Abstract
OBJECTIVE: To evaluate omeprazole prescriptions for older adults based on the Beers Criteria, with an analysis of indications and duration of use longer than eight weeks.
METHODS: In this retrospective cross-sectional study, data were collected from the electronic medical records of older adults with an omeprazole prescription seen at two health care units in Curitiba, Brazil, between June and August 2019. Data were subjected to descriptive statistical analysis, Student t and χ2 tests. RESULTS: Medical records of 386 patients were analyzed, and 69.95% were female. The mean age was 71 (SD, 8.15) years. Most patients had incomplete primary education (50.52%) and income level ranging from one to two Brazilian minimum monthly wages (39.90%). No indication for omeprazole prescription was found in 23.83% of medical records. Use longer than eight weeks was predominant for all indications in 96.60% of medical records. Duration of use more extended than the Beers Criteria recommendation was independent of sex (p = 0.327), education (p = 0.805), and income level (p = 0.629). A relationship between polypharmacy and long-term drug use was demonstrated (p < 0.001). CONCLUSION: The results of this study suggest the need for periodic review of omeprazole prescriptions considering deprescribing when they appropriate.
Publisher
Sociedade Brasileira de Geriatria e Gerontologia
Reference26 articles.
1. Wallace JL, Sharkey KA. Farmacoterapia da acidez gástrica, úlceras pépticas e doença do refluxo gastroesofágico. In: Brunton LL, Chabner BA, Knollmann BC. As bases farmacológicas da terapêutica de Goodman & Gilman. 12th. ed. Porto Alegre: AMGH; 2012. p. 1310-1311.
2. Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc. 2018;93(2):240-6. https://doi.org/10.1016/j.mayocp.2017.10.022
3. Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Uso racional de medicamentos: temas selecionados. Brasília: Ministério da Saúde; 2012.
4. Brasil. Ministério da Saúde. Relação Nacional de Medicamentos Essenciais: RENAME 2020. Brasília: Ministério da Saúde; 2020.
5. Eusebi HL, Rabitti S, Artesani ML, Gelli D, Montagnani M, Zagari RM, et al. Proton pump inhibitors: risks of long-term use. J Gastroenterol Hepatol. 2017;32(7):1295-302. https://doi.org/10.1111/jgh.13737